UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the...
0001850079Telesis Bio Inc.false00018500792023-01-092023-01-09 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C...
-- Record revenue of $9M in 4QFY22; Increase of 191% over 4QFY21 -- BioXp® Revenue increased by 131% to $3M...
P10Y3Mone month--12-31false0001850079Q30001850079us-gaap:FurnitureAndFixturesMember2021-12-3100018500792022-04-012022-06-300001850079us-gaap:Comm...
-- Record revenue of $6.7M in 3QFY22; Increase of 140% over $2.8M 3QFY 2021 -- BioXp® Kit Revenue increased to...
false12-31Telesis Bio Inc.000185007900018500792022-11-072022-11-07 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C...
SAN DIEGO, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: DNAY), a leader in automated multi-omic and...
0001850079falseCodex DNA, Inc.00018500792022-10-242022-10-24 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C...
SAN DIEGO, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: DNAY), a leader in automated multi-omic and...
SAN DIEGO, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a leader in automated multi-omic...
SAN DIEGO, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop...
SAN DIEGO, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop...
SAN DIEGO, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:August 19, 2022...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.